QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Sable Offshore Corp. ("Sable" or the "Company") (NYSE:SOC) today provided an update regarding its ongoing litig...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-10-09/texas-oil-driller-taps-trump-s-team-to-save-california-crude-project?embedde...

Core News & Articles

Sable Offshore Corp. ("Sable" or the "Company")(NYSE:SOC) in its ongoing case, Sable Offshore Corp., et al. v. ...

Core News & Articles

Gainers Vivakor (NASDAQ: VIVK) shares increased by 196.1% to $0.79 during Monday's after-market session. The market value ...

Core News & Articles

Sable Offshore Corp. ("Sable" or the "Company")(NYSE: SOC) has submitted its formal Request for Approval of Res...

Core News & Articles

Sable Offshore (NYSE:SOC) reported quarterly losses of $(1.40) per share which missed the analyst consensus estimate of $(0.64)...

Core News & Articles

https://www.santabarbara.courts.ca.gov/tentative-ruling/25cv02247

Core News & Articles

Roth Capital analyst Leo Mariani maintains Sable Offshore (NYSE:SOC) with a Buy and lowers the price target from $38 to $37.

Core News & Articles

Sable Offshore Corp. ("Sable" or the "Company") (NYSE:SOC) today announced the commencement of an underwritten ...

Core News & Articles

Benchmark analyst Subash Chandra maintains Sable Offshore (NYSE:SOC) with a Buy and raises the price target from $37 to $47.

Core News & Articles
Market-Moving News for May 19th
05/19/2025 11:16:14

BCLI: 120% | BrainStorm Cell Therapeutics shares are trading higher after the company received FDA clearance to initiate its Ph...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION